BackKaryopharm Therapeutics Overview

Karyopharm Therapeutics Profit Margin

Profitability ratio analysis for KPTI.

Quarterly Profit Margin

-63.86%
↑ 18.31% YoY

As of Mar 2026

Annual Profit Margin (TTM)

-129.02%
↓ 174.16% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin